Malaria Parasites Don't Change RNA Levels in Response to Antifolates
Author Information
Author(s): Ganesan Karthikeyan, Ponmee Napawan, Jiang Lei, Fowble Joseph W., White John, Kamchonwongpaisan Sumalee, Yuthavong Yongyuth, Wilairat Prapon, Rathod Pradipsinh K.
Primary Institution: University of Washington
Hypothesis
How do malaria parasites respond at the genetic level to lethal antifolate drugs?
Conclusion
Malaria parasites do not significantly increase RNA levels for key metabolic pathways when exposed to lethal antifolates.
Supporting Evidence
- Malaria parasites showed no significant changes in RNA levels for the target pathways after drug treatment.
- 50% of the parasites became non-viable within 6 hours of drug exposure.
- Only small, non-protective changes in RNA were detected in dying cells.
Takeaway
When malaria parasites are given a strong medicine, they don't change their genes like we thought they would, which might make them more vulnerable to the medicine.
Methodology
The study used DNA microarrays to analyze gene expression in malaria parasites treated with the antifolate WR99210.
Potential Biases
Potential bias in the interpretation of microarray data due to the complexity of gene regulation in parasites.
Limitations
The study primarily focused on a single drug and specific parasite strains, which may limit the generalizability of the findings.
Participant Demographics
The study involved Plasmodium falciparum clones Dd2 and B1G9, which are derived from different geographical regions.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website